{"id":"CHEMBL106","canonicalSmiles":"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"RFHAOTPXVQNOHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCONAZOLE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Canesten oral","Diflucan","Diflucan In Sodium Chloride","Diflucan one","Fluconazole","Fluconazole In Sodium Chloride","Triflucan"],"synonyms":["Alkanazole","BAYT-006267","BAYT006267","Diflucan","Difluconazole","Fluconazole","Fluconazoli","NSC-758661","UK-49,858","UK-49858","Zoltec"],"crossReferences":{"DailyMed":["fluconazole"],"PubChem":["144204972","144209438","144210898","170464782","174007447","26748877","26753743","49666152"],"Wikipedia":["Fluconazole"],"drugbank":["DB00196"],"chEBI":["46081"]},"childChemblIds":["CHEMBL1163001"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 4 approved and 32 investigational indications."}
{"id":"CHEMBL1079","canonicalSmiles":"Clc1ccc2nsnc2c1NC1=NCCN1","inchiKey":"XFYDIVBRZNQMJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIZANIDINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tizanidine","Zanaflex"],"crossReferences":{"DailyMed":["tizanidine%20hydrochloride"],"PubChem":["144205429","170465419","26754628","29216212","29216213","90340638"],"Wikipedia":["Tizanidine"],"drugbank":["DB00697"],"chEBI":["63629"]},"childChemblIds":["CHEMBL1200329"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["HP_0001257","EFO_0000756","MONDO_0002959","HP_0003419","HP_0006986","MONDO_0043510","EFO_0003843","HP_0000023"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for spasticity and has 5 investigational indications."}
{"id":"CHEMBL1092067","canonicalSmiles":"OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O","inchiKey":"ZCXUVYAZINUVJD-AHXZWLDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDEOXYGLUCOSE F 18","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1086863","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fludeoxyglucose f18"],"synonyms":["(18f)-fdg","(18f)-fluorodeoxyglucose","(18f)fdg","(18f)fluoro-2-deoxyglucose","(18f)fluorodeoxyglucose","18-FDG","18-f fdg","18FDG","18f","18f-fdg","18f-fluorodeoxyglucose","2-deoxy-2-(18f)fluoro-d-glucose","2-deoxy-2-fluoro-d-glucose, f-18","Fdg f-18","Fdg-pet","Fludeoxyglucose ((sup 18)f)","Fludeoxyglucose (18f)","Fludeoxyglucose f 18","Fludeoxyglucose f(sup 18)","Fludeoxyglucose f-18","Fludeoxyglucose, f-18","Fluglucoscan","Fluorine (18f) fludeoxyglucose","Fluorine f 18 fluorodeoxyglucose","Fluorodeoxyglucose f 18","Fluorodeoxyglucose f18","S8FDG"],"crossReferences":{"DailyMed":["fludeoxyglucose%20f-18"],"chEBI":["31617"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 31 investigational indications."}
{"id":"CHEMBL113178","canonicalSmiles":"C[Se]CC[C@H](N)C(=O)O","inchiKey":"RJFAYQIBOAGBLC-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENOMETHIONINE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-760370","Selenomethionine"],"crossReferences":{"PubChem":["144206245","50125779"],"drugbank":["DB11142"],"chEBI":["30021"]},"childChemblIds":["CHEMBL1201054"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 8 investigational indications."}
{"id":"CHEMBL1135","canonicalSmiles":"CN(C)CCO","inchiKey":"UEEJHVSXFDXPFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLAMINOETHANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMAE","Dimethylaminoethanol","N,N-Dimethylaminoethanol"],"crossReferences":{"PubChem":["144206714","144209019","144213161","29215350"],"Wikipedia":["Dimethylethanolamine"],"drugbank":["DB13352"],"chEBI":["271436"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1163068","canonicalSmiles":"C[C@@H](O)[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"UPVAPSGKXAAHBG-CKTDUXNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163068","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03355"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173","canonicalSmiles":"O=c1[nH]cc(I)c(=O)[nH]1","inchiKey":"KSNXJLQDQOIRIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1173","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03554"],"chEBI":["43636"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182714","canonicalSmiles":"CNCCCOc1cc(F)c(-c2c(Cl)nc3ncnn3c2N[C@@H](C)C(F)(F)F)c(F)c1","inchiKey":"ZUZPCOQWSYNWLU-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEVIPABULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cevipabulin"],"crossReferences":{"drugbank":["DB12533"]},"childChemblIds":["CHEMBL2107323","CHEMBL2107322","CHEMBL262314"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200436","canonicalSmiles":"C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"QSLJIVKCVHQPLV-PEMPUTJUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXANDROLONE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anavar","Oxandrin","Oxandrolone"],"synonyms":["Lonavar","NSC-67068","Oxandrolone","Oxandrolone ciii","Provitar","SC 11585","SC-11585","Vasorome"],"crossReferences":{"DailyMed":["oxandrolone"],"Wikipedia":["Oxandrolone"],"drugbank":["DB00621"],"chEBI":["7820"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_84","EFO_0007312","EFO_0005938","EFO_0008572","EFO_1001006","EFO_0007067","EFO_0009516","Orphanet_881","EFO_1001250"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200509","canonicalSmiles":"CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"OWAUGAMNPZHEOJ-YKZVIGSYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"HISTRELIN ACETATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201255","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Supprelin","Supprelin la","Vantas"],"synonyms":["Histrelin acetate"],"crossReferences":{"DailyMed":["histrelin%20acetate"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0008315"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for prostate cancer and prostate adenocarcinoma."}
{"id":"CHEMBL1200711","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)OCC.CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)OCC","inchiKey":"DTMGIJFHGGCSLO-FIAQIACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEGA-3-ACID ETHYL ESTERS","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dualtis","Lovaza","Nebbaro","Omacor","Omega-3-acid ethyl esters","Omtryg","Prestylon","Teromeg"],"synonyms":["Doconexent (dha ethyl ester)","Icosapent (epa ethyl ester)","K-85","K85","Omega-3 acid ethyl esters","Omega-3 marine triglycerides","Omega-3-acid ethyl ester","Omega-3-acid ethyl esters","Omega-3-acid ethyl esters type a","TAK-085"],"crossReferences":{"DailyMed":["omega-3-acid%20ethyl%20esters","omega-3-acid%20ethyl%20esters%20type%20a"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 59 investigational indications."}
{"id":"CHEMBL1200817","canonicalSmiles":"CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1.Cl","inchiKey":"UXBPQRGCVJOTNT-COBSGTNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMETHADYL ACETATE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1514","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Cardiotoxicity"],"year":2001},"tradeNames":["Orlaam"],"synonyms":["LAAM","Levacetylmethadol hydrochloride","Levomethadyl acetate hcl","Levomethadyl acetate hydrochloride","MK-790","MK790"],"crossReferences":{"PubChem":["85273814"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993. It was withdrawn in European Union and  United States initially in 2001 due to Cardiotoxicity."}
{"id":"CHEMBL1201015","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Al+3]","inchiKey":"WCOATMADISNSBV-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM ACETATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buro-sol concentrate","Domeboro"],"synonyms":["Acetic acid, aluminum salt","Acetic acid, aluminum salt (3:1)","Aluminium acetate","Aluminum acetate","Buro-sol"],"crossReferences":{"DrugCentral":["4998"],"drugbank":["DB14518"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1201065","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)N=C([S-])NC1=O.[Na+]","inchiKey":"LYZGJWXNOGIVQA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMYLAL SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL440","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surital"],"synonyms":["NSC-759558","Sodium thiamylal","Thiamylal sodium","Thiamylal sodium salt"],"crossReferences":{"PubChem":["144205070","26749789"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201068","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2.Cl","inchiKey":"UGVNGSMLNPWNNA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIOMAZINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201210","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Largon"],"synonyms":["Propiomazine hcl","Propiomazine hydrochloride"],"crossReferences":{"chEBI":["8492"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201134","canonicalSmiles":"CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1","inchiKey":"WGFOBBZOWHGYQH-MXHNKVEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUBIPROSTONE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amitiza"],"synonyms":["Lubiprostone","RU-0211"],"crossReferences":{"DailyMed":["lubiprostone"],"PubChem":["144206539"],"Wikipedia":["Lubiprostone"],"drugbank":["DB01046"]},"linkedTargets":{"rows":["ENSG00000114859"],"count":1},"linkedDiseases":{"rows":["MONDO_0004880","HP_0012532","EFO_0000555","MONDO_0005180","EFO_0000764","HP_0002019","MONDO_0002203"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL1201481","drugType":"Small molecule","blackBoxWarning":false,"name":"PORFIMER SODIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Photofrin"],"synonyms":["CL 184,116","CL-184,116","CL-184116","Photobarr","Photofrin ii","Porfimer sodium","Profimer sodium"],"crossReferences":{"DailyMed":["porfimer%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for neoplasm and has 14 investigational indications."}
{"id":"CHEMBL1201532","drugType":"Unknown","blackBoxWarning":false,"name":"THYROTROPIN","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thytropar"],"synonyms":["Thyrotrophin","Thyrotropin","Thyrotropin (bovine)"],"linkedTargets":{"rows":["ENSG00000165409"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000501","EFO_0000641"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 3 investigational indications."}
{"id":"CHEMBL1201599","drugType":"Unknown","blackBoxWarning":false,"name":"GLOBULIN, IMMUNE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Baygam","Flebogamma","Gammagard","Gammagee","Gammar","Gammar-p i.v.","Gamulin","Gamunex","Immu-g","Immuglobin","Octagam","Sandoglobulin","Venoglobulin-i","Venoglobulin-s"],"synonyms":["Bt-295","Flebogamma dif","Flebogammadif","Gamastan","Gammagard liquid","Gammaplex","Globulin, immune","Globulin, immune human serum","Human gammaglobulin","Human igg","Human immune globulin g","Human immunoglobulin g","Human normal immunoglobulin","Immune globulin (human)","Immune globulin human","Immunoglobulin g (human)","Immunoglobulin g, human","Immunoglobulin human normal","Kiovig","NPB-01","Newgam","Normal immunoglobulins","Privigen"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 56 investigational indications."}
{"id":"CHEMBL1201668","drugType":"Protein","blackBoxWarning":false,"name":"NESIRITIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Natrecor"],"synonyms":["Bnp-32","Brain natriuretic peptide 32","C01DX19","Nesiritide","Nesiritide Recombinant","Nesiritide recombinant"],"crossReferences":{"Wikipedia":["Nesiritide"]},"linkedTargets":{"rows":["ENSG00000169418"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0005149","HP_0002094","EFO_0000318","EFO_0001645","EFO_0000756","HP_0001919","EFO_0000701","EFO_0000373","EFO_0000319","EFO_0001073","EFO_1002048","EFO_0000537","EFO_0003144","EFO_0008583","EFO_0000612","EFO_0000400","HP_0030680","EFO_0005672","EFO_1000899","HP_0000842"],"count":21},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for cardiovascular disease and has 17 investigational indications."}
{"id":"CHEMBL1201836","drugType":"Antibody","blackBoxWarning":true,"name":"OFATUMUMAB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arzerra"],"synonyms":["2F2","GSK-1841157","GSK1841157","HUMAX-CD20","HUMAX-CD20 2F2","HUMAX-CD20, 2F2","HUMAX-CD20-2F2","Ofatumumab"],"crossReferences":{"DailyMed":["ofatumumab"],"DrugCentral":["4951"],"Wikipedia":["Ofatumumab"]},"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0000756","EFO_1001469","EFO_0005952","MONDO_0003541","EFO_0000565","EFO_0000309","EFO_0004289","EFO_0004255","EFO_0000183","MONDO_0002083","EFO_1000749","EFO_0004719","EFO_0009441","EFO_0000616","MONDO_0013730","EFO_0000685","EFO_0000765","EFO_0000220","EFO_0000403","MONDO_0000870","EFO_0003929","EFO_0000311","MONDO_0005301","EFO_0000095","MONDO_0001023","EFO_0000574","MONDO_0018906"],"count":28},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 4 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1206232","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O","inchiKey":"WDOGQTQEKVLZIJ-WAYWQWQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSBRETABULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Combretastatin a-4 phosphate","Combretastatin a4 phosphate","Fosbretabulin","Phosbretabulin"],"crossReferences":{"drugbank":["DB12577"]},"childChemblIds":["CHEMBL2105643","CHEMBL1972559","CHEMBL289351","CHEMBL263994"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004683","EFO_0006859","EFO_1001901","MONDO_0002108","MONDO_0008170","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1213033","canonicalSmiles":"CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1","inchiKey":"NZLBHDRPUJLHCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRINDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aprindine","COMPOUND 99170"],"crossReferences":{"PubChem":["50112831","90340712"],"Wikipedia":["Aprindine"],"drugbank":["DB01429"]},"childChemblIds":["CHEMBL2104501"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1231099","canonicalSmiles":"O=C(NC(=O)c1cc(F)c(F)cc1Cl)Nc1cc(F)ccc1N1CCC(C(=O)O)CC1","inchiKey":"KAJJGOCSAXKXBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231099","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210573"],"drugbank":["DB07396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231375","canonicalSmiles":"Cc1cccc2c1C(=O)[C@]1(O)CCN(c3ccccc3)C1=N2","inchiKey":"NJBBBRZNBVLTRZ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231375","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231498","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OCCCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)[C@@H](O)[C@H]1O","inchiKey":"KBOGUFFJCBPJEH-SQGSUPJISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04651"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231529","canonicalSmiles":"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCCNCCCCNCCCN)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1","inchiKey":"FOUFFVYWFNBHHH-YNGSZULRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLEOMYCIN A6","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bleomycin a6","Boanmycin","Pingyangmycin a6","Zhengguangmycin a6"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1231667","canonicalSmiles":"CC1=C(C(=O)Nc2ccccc2)SCCO1","inchiKey":"GYSSRZJIHXQEHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1724944"],"crossReferences":{"PubChem":["144209186","144211023","26752286","4264006"],"drugbank":["DB04657"],"chEBI":["3405"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234048","canonicalSmiles":"CCCCCCCCCCCCO[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O","inchiKey":"NLEBIOOXCVAHBD-YHBSTRCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234048","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03279"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235115","canonicalSmiles":"O=C(COP(=O)(O)O)[C@@H](O)[C@@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"XPYBSIWDXQFNMH-PQLUHFTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235115","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02512"],"chEBI":["49093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236788","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)O[C@H](C1CC1)C=C2","inchiKey":"HWJPWWYTGBZDEG-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-ICLAPRIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-Iclaprim"],"crossReferences":{"drugbank":["DB08741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125","canonicalSmiles":"CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C","inchiKey":"PQLXHQMOHUQAKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MILTEFOSINE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Impavido","Miltefosine","Miltex"],"synonyms":["D-18506","HDPC","Miltefosine","NSC-605583","NSC-758968"],"crossReferences":{"DailyMed":["miltefosine"],"PubChem":["144205019","170465622","26749044","484338"],"Wikipedia":["Miltefosine"],"drugbank":["DB09031"],"chEBI":["75283"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL126726","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1OCCCOc1ccc(Br)cc1","inchiKey":"MPXYCOHVHSXSDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126726","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04007"]},"childChemblIds":["CHEMBL1203258"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1375743","canonicalSmiles":"Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"ZCBZSCBNOOIHFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIPRASIDONE HYDROCHLORIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL708","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geodon","Zeldox","Ziprasidone hydrochloride"],"synonyms":["CP-88,059-1","CP-88059-1","CP-880591","Ziprasidone hydrochloride","Ziprasidone hydrochloride hydrate","Ziprasidone hydrochloride monohydrate"],"crossReferences":{"DailyMed":["ziprasidone%20hydrochloride"],"PubChem":["90340940"],"chEBI":["32314"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000289","EFO_0004269","EFO_0005306","EFO_0009963","HP_0000713"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 6 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL145","canonicalSmiles":"O=C(O)/C=C/c1ccc(O)c(O)c1","inchiKey":"QAIPRVGONGVQAS-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFFEIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-PROPENOIC ACID, 3-(3,4-DIHYDROXYPHENYL)-, (2E)-","Caffeic acid","Cinnamic acid, 3,4-dihydroxy-","NSC-57197","NSC-623438","Trans-3,4-dihydroxycinnamic acid","Trans-caffeic acid","trans-Caffeate"],"crossReferences":{"PubChem":["106262","124883134","124883135","124883138","26746990","26751505","50104061","50104062","50104063","50104064","50104065","56422203","85231345","855772","90340699"],"Wikipedia":["Caffeic_acid"],"drugbank":["DB01880"],"chEBI":["16433"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL151","canonicalSmiles":"O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"IQPNAANSBPBGFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUTEOLIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyanidenon-1470","Digitoflavone","Flacitran","Luteolin","Luteoline","Luteolol","Salifazide","Weld lake","Yama kariyasu"],"crossReferences":{"PubChem":["11112366","11112367","124882293","124882294","124882295","26725303","26754151","26754152","46500347","56463543","85256900"],"Wikipedia":["Luteolin"],"drugbank":["DB15584"],"chEBI":["15864"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1521","canonicalSmiles":"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1","inchiKey":"HUNXMJYCHXQEGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZALEPLON","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sonata","Zaleplon"],"synonyms":["CL 284,846","CL-284846","L-846","L846","LJC 10846","LJC-10846","SKP-1041","ZAL-846","Zaleplon","Zaleplon civ","Zerene"],"crossReferences":{"DailyMed":["zaleplon"],"PubChem":["144205425","170465168","26719706","29216208"],"Wikipedia":["Zaleplon"],"drugbank":["DB00962"],"chEBI":["10102"]},"linkedTargets":{"rows":["ENSG00000113327","ENSG00000163288"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0001072","MONDO_0002050","HP_0000726","EFO_0005230","EFO_0004698"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for insomnia and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1589896","canonicalSmiles":"Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O","inchiKey":"OXLZNBCNGJWPRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOPRENALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexoprenaline","Ipradol","ST-1512","ST1512"],"crossReferences":{"PubChem":["50112775"],"drugbank":["DB08957"]},"childChemblIds":["CHEMBL2104813"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1614701","canonicalSmiles":"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21","inchiKey":"CYOHGALHFOKKQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELUMETINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ARRY-142886","ARRY-886","AZD-6244","AZD6244","Azd-6244","Selumetinib"],"crossReferences":{"DailyMed":["selumetinib%20sulfate"],"PubChem":["144206913","170466898","174006431"],"drugbank":["DB11689"],"chEBI":["90227"]},"childChemblIds":["CHEMBL2105684"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0000365","EFO_0000558","EFO_0000756","EFO_1000231","MONDO_0007254","EFO_0008514","EFO_1000657","EFO_0000708","MONDO_0021063","EFO_0000228","EFO_0000272","MONDO_0001187","EFO_1001951","MONDO_0016691","EFO_1001952","EFO_1001480","EFO_1000044","EFO_0000339","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000501","MONDO_0018531","EFO_0000641","EFO_0004606","EFO_0000760","EFO_0000707","EFO_0002617","EFO_0000616","EFO_0002618","EFO_1000616","EFO_1001956","EFO_0000220","MONDO_0002108","MONDO_0021321","EFO_0000503","EFO_0000403","Orphanet_636","EFO_1001968","EFO_0003060","EFO_0005221","EFO_0000311","EFO_1000489","MONDO_0000544","EFO_0000658","EFO_0009254","EFO_0005537","EFO_0004142","MONDO_0002367","EFO_0001378","MONDO_0024880","EFO_1001950","MONDO_0021637"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 4 approved and 42 investigational indications."}
{"id":"CHEMBL1614707","canonicalSmiles":"FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1","inchiKey":"ZTFBIUXIQYRUNT-MDWZMJQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUBRITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mubritinib","TAK-165"],"crossReferences":{"drugbank":["DB12682"]},"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003865","EFO_0003893","EFO_0003860","MONDO_0021117"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1644029","canonicalSmiles":"O=[N+]([O-])[O-].[K+]","inchiKey":"FGIUAXJPYTZDNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM NITRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-252","E252","INS NO.252","INS-252","Kali nitricum","NSC-57632","Nitre","Potassium nitrate","Saltpeter","Saltpetre"],"crossReferences":{"DrugCentral":["4263"],"PubChem":["144208779","144213706"],"Wikipedia":["Potassium_nitrate"],"drugbank":["DB11090"],"chEBI":["63043"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1707454","canonicalSmiles":"Cc1ccccc1/N=N/c1ccc(/N=N/c2c(O)ccc3ccccc23)c(C)c1","inchiKey":"RCTGMCJBQGBLKT-PAMTUDGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCARLET RED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aka501","Biebrich scarlet red","C.I. 26105","C.i. solvent red 24","CI-26105","Ci 26105","Grasal brilliant red b","NSC-10472","Scarlet red","Solvent red 24","Solvent red 24 (scarlet red)","Sudan iv"],"crossReferences":{"PubChem":["144205860","170465710","29217837","539817"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1716","canonicalSmiles":"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1.Cl","inchiKey":"ZPMVNZLARAEGHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROHEPTADINE HYDROCHLORIDE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL516","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyproheptadine Hydrocloride","Cyproheptadine hydrochloride","Periactin"],"synonyms":["Cyproheptadine HCl","Cyproheptadine hcl","Cyproheptadine hydrochloride","Cyproheptadine hydrochloride hydrate","Cyproheptadine hydrochloride sesquihydrate","NSC-169911","NSC-759282","Periactine","Peritol"],"crossReferences":{"DailyMed":["cyproheptadine%20hydrochloride"],"PubChem":["50105994","50105995","56422142","855651"],"chEBI":["59695"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007141","EFO_0003956","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL17350","canonicalSmiles":"C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1","inchiKey":"QEMSVZNTSXPFJA-HNAYVOBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAXOPRODIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-101,606","CP-101606","Cp-101,606","Traxoprodil"],"crossReferences":{"Wikipedia":["Traxoprodil"]},"childChemblIds":["CHEMBL3989673"],"linkedTargets":{"rows":["ENSG00000273079","ENSG00000176884"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009","MONDO_0005180","EFO_0000712"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL175105","canonicalSmiles":"C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O","inchiKey":"UIARLYUEJFELEN-DMVVYWCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06469"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1789842","canonicalSmiles":"CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2.O=C(O)/C=C\\C(=O)O","inchiKey":"IREJFXIHXRZFER-PCBAQXHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDACATEROL MALEATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1095777","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arcapta neohaler","Onbrez breezhaler"],"synonyms":["Indacaterol (as maleate)","Indacaterol maleate","Indacterol maleate","QAB-149-AFA","QAB149-AFA"],"crossReferences":{"chEBI":["68573"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000464","EFO_0006505","MONDO_0004979","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1874750","canonicalSmiles":"COc1cc(/C=C/C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC","inchiKey":"RCUDFXMNPQNBDU-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINEPAZIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"],"classes":["Hematological toxicity"],"year":1987},"tradeNames":[],"synonyms":["Cinepazide","Cinepazide maleate","MD 67350 FREE BASE","MD 67350 [AS MALEATE]","MD-67350 FREE BASE"],"crossReferences":{"PubChem":["50125834"],"drugbank":["DB12123"]},"childChemblIds":["CHEMBL4303265"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for cardiovascular disease and has 1 investigational indication. It was withdrawn in Spain  in 1987 due to Hematological toxicity."}
{"id":"CHEMBL1951095","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12","inchiKey":"HLFSMUUOKPBTSM-ISIOAQNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERAVACYCLINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tp-434"],"synonyms":["Eravacycline","TP-434"],"crossReferences":{"DailyMed":["eravacycline%20dihydrochloride"],"drugbank":["DB12329"]},"childChemblIds":["CHEMBL2219414"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for bacterial disease and infection and has 4 investigational indications."}
{"id":"CHEMBL1980825","canonicalSmiles":"O=C1CC[C@H](NC(=O)Cc2ccccc2)C(=O)N1","inchiKey":"OQGRFQCUGLKSAV-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTINEOPLASTON A10","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antineoplaston a 10","Antineoplaston a10","Atengenal"],"crossReferences":{"PubChem":["489176"],"drugbank":["DB11702"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 41 investigational indications."}
{"id":"CHEMBL20684","canonicalSmiles":"COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1","inchiKey":"URCVCIZFVQDVPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-751","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-751","E 7010","E-7010","NSC-742134"],"crossReferences":{"drugbank":["DB12254"]},"childChemblIds":["CHEMBL1830238"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000173213","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0001642","EFO_0000681","MONDO_0007254","MONDO_0000870","EFO_0003060","EFO_0000621","MONDO_0008315","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL207228","canonicalSmiles":"Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2O","inchiKey":"AYKGPCNWPACUQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207228","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07218"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL209720","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](F)[C@@H](COC(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]1","inchiKey":"GJNIPWYJQUGERM-BFLUCZKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL209720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103914","canonicalSmiles":"O=c1[nH]sc2cc(Cl)ccc12","inchiKey":"POPOYOKQQAEISW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICLATONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FER-1443","Ticlatone"],"crossReferences":{"PubChem":["170466391"],"drugbank":["DB13613"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105059","canonicalSmiles":"O=C(OCCN1CCOCC1)c1cccnc1Nc1cccc(C(F)(F)F)c1","inchiKey":"LDXSPUSKBDTEKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORNIFLUMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morniflumate","UP 164","UP-164"],"crossReferences":{"PubChem":["170466184"],"drugbank":["DB09285"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105141","canonicalSmiles":"CC(CCN1CCN(c2ccc(F)cc2)CC1)NC(=O)c1cccnc1","inchiKey":"RSKQGBFMNPDPLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIAPRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1709 CERM","1709-CERM","1709CERM","J10.716F","Niaprazine","Nopron"],"crossReferences":{"drugbank":["DB13687"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105668","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.O=C(O)/C=C\\C(=O)O","inchiKey":"IPACOHTZCSBGBV-WUXDIRCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORVEPITANT MALEATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105667","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-823296B","GW823296B","Orvepitant maleate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106388","canonicalSmiles":"[Ca+2].[OH-].[OH-]","inchiKey":"AXCZMVOFGPJBDE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM HYDROXIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcarea caustica","Calcium hydroxide","Calcium hydroxide (ca(oh)2)","Calcium hydroxide solution","E-526","INS NO.526","INS-526","Lime hydrate","Lime water","Slaked lime","Slaked-lime"],"crossReferences":{"chEBI":["31341"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106561","canonicalSmiles":"CCOC(=O)NNc1ccc(N(CC)CC(C)O)nn1","inchiKey":"QLTVVOATEHFXLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CADRALAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cadral","Cadralazine"],"crossReferences":{"PubChem":["144206697","170466021"],"drugbank":["DB13452"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107112","canonicalSmiles":"CC(C)(C)C(=O)SCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"BISFDZNIUZIKJD-XDANTLIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIXOCORTOL PIVALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cortisol 21-thiol","JO-1016","Tixocortol","Tixocortol 21-pivalate","Tixocortol pivalate","Tixocortol-21-pivalate"],"crossReferences":{"chEBI":["63564"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107756","canonicalSmiles":"C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)OCCC)C(CCC(=O)OCCO)=C4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC","inchiKey":"LHXFPSQJODNWEW-DVNHMXKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEMUTEPORFIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lemuteporfin","QLT-0074","QLT0074"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107773","canonicalSmiles":"Cc1cc(OCC(=O)O)c(C)cc1CCN[C@@H](C)[C@H](O)c1ccc(O)cc1","inchiKey":"VMMYRRFPMAGXNP-BTYIYWSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITOBEGRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KUC-7483","Kuc-7483","Ritobegron"],"crossReferences":{"drugbank":["DB12080"]},"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_1000781","HP_0000011"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108051","drugType":"Antibody","blackBoxWarning":false,"name":"STAMULUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MYO-029","Stamulumab"],"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_263","Orphanet_98895","Orphanet_269"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108817","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 EPRATUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lymphocide"],"synonyms":["90Y-HLL2","90Y_HLL2","Epratuzumab (y 90)","S9S0Y-HLL2","Yttrium y 90 epratuzumab","Yttrium y-90 epratuzumab"],"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000574"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108821","drugType":"Unknown","blackBoxWarning":false,"name":"TRYPSIN, CRYSTALLIZED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Parenzyme"],"synonyms":["Crystallized trypsin","EC 3.4.21.4","Trypsin","Trypsin crystallized","Trypsin recombinant porcine","Trypsin, crystallized","Trypsin, unspecified form","Trypsin,crystallized"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108872","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLEVAMER SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GT-160-246","GT160-246","Tolevamer sodium"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108939","drugType":"Unknown","blackBoxWarning":false,"name":"CHOLERA VACCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cholera vaccine","Cholera vaccine cvd 103-hgr","Cholera vaccine live oral","Cholera, live attenuated","Cvd 103-hgr","Cvd hgr 103 vaccine","PXVX-0200","Vaxchora"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109494","drugType":"Antibody","blackBoxWarning":false,"name":"A27.15","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A27.15"],"linkedTargets":{"rows":["ENSG00000072274"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0002428","EFO_0001378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109535","drugType":"Antibody","blackBoxWarning":false,"name":"KBPA-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-101","KBPA-101","Kbpa-101"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109614","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-5117","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-5117","Medi 5117"],"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110954","canonicalSmiles":"CC1(C)CC(C)(C)CC(C)(N)C1","inchiKey":"OGZQTTHDGQBLBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERAMEXANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neramexane"],"crossReferences":{"drugbank":["DB04926"]},"childChemblIds":["CHEMBL2106798"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000174343","ENSG00000129749","ENSG00000176884","ENSG00000198785"],"count":9},"linkedDiseases":{"rows":["HP_0000360","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2146161","canonicalSmiles":"CC1=C\\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC\\C=C\\1.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"YVMBAUWDIGJRNY-BESUKNQGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIKAMYCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pyostacine"],"synonyms":["Mikamycin","Pristinamycin","Pyostacine 500","RP 7293","RP-7293","SKF-7988"],"crossReferences":{"DrugCentral":["3489"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL2181929","canonicalSmiles":"CC1(C)Oc2cc(NS(C)(=O)=O)ccc2N(c2ccc(F)cc2)C1=O","inchiKey":"AZNHWXAFPBYFGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2181929","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220491","canonicalSmiles":"CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21","inchiKey":"HCRKCZRJWPKOAR-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRINZOLAMIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azopt"],"synonyms":["AL-4862","Azopt","Brinzolamide","NSC-760050"],"crossReferences":{"DailyMed":["brinzolamide"],"PubChem":["170464926","56463043"],"Wikipedia":["Brinzolamide"],"drugbank":["DB01194"],"chEBI":["3176"]},"linkedTargets":{"rows":["ENSG00000104267"],"count":1},"linkedDiseases":{"rows":["EFO_0009784","EFO_0004190","EFO_1001069","EFO_0000516","HP_0000639"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2206292","canonicalSmiles":"CC(C)CNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1","inchiKey":"DJRDLCHHQYHQQK-UKIBZPOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03654764","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03654764"],"crossReferences":{"drugbank":["DB12360"]},"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0005854"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL221181","canonicalSmiles":"N#Cc1ccc2c(-c3cc4cc(CN5CCC(CN)CC5)ccc4[nH]3)n[nH]c2c1","inchiKey":"WBKUBPBCFYCSRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221181","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221390","canonicalSmiles":"CC(C)(C)OC(=O)N[C@@H](CC(=O)OCc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)OC(C)(C)C","inchiKey":"SVNKEDMVAQBLLN-SVBPBHIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVERSIN 121","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Reversin 121"],"crossReferences":{"drugbank":["DB14072"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218861","canonicalSmiles":"CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21","inchiKey":"GDFGTRDCCWFXTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINAGOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinagolide"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["Orphanet_64739","EFO_0001065"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2359370","drugType":"Small molecule","blackBoxWarning":false,"name":"MECOBALAMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asimil b-12","B-max"],"synonyms":["Mecobalamin"],"crossReferences":{"DrugCentral":["4600"],"PubChem":["144206526"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anemia (phenotype) and has 3 investigational indications."}
{"id":"CHEMBL2364624","canonicalSmiles":"O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1","inchiKey":"GXALXAKNHIROPE-QAQDUYKDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADIGASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LCQ-908-NXA","LCQ-908NXA","LCQ908-NXA","Lcq-908","Lcq908 - dgat-1-inhibitor","Pradigastat"],"crossReferences":{"drugbank":["DB12866"]},"childChemblIds":["CHEMBL2364625"],"linkedTargets":{"rows":["ENSG00000185000"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0018637","EFO_0003095","EFO_0001421","MONDO_0037748","EFO_0003047","MONDO_0005148","HP_0002019"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL238659","canonicalSmiles":"NNC(=O)c1cn2ccc3ccccc3c2n1","inchiKey":"WSNWYZBDIKCPIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL238659","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08758"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275638","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2ccccc12","inchiKey":"VHBFFQKBGNRLFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-phenyl-.gamma.-benzopyrone","2-phenyl-1,4-benzopyrone","Asmacoril","Chromocor","Cromaril","Cromarile","Flavone","NSC-19028"],"crossReferences":{"PubChem":["124890241","144210185","144214020","17389570","26752852","56462798"],"drugbank":["DB07776"],"chEBI":["42491"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL277474","canonicalSmiles":"Cc1cc(=O)n(-c2ccccc2)n1C","inchiKey":"VEQOALNAAJBPNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTIPYRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antipyrin","Antipyrine","Antipyrinum","NSC-7945","Phenazon","Phenazone"],"crossReferences":{"PubChem":["104171279","11112159","144203893","144208798","144213343","170465510","26753718","56320742"],"Wikipedia":["Phenazone"],"drugbank":["DB01435"],"chEBI":["31225"]},"linkedTargets":{"rows":["ENSG00000095303"],"count":1},"linkedDiseases":{"rows":["HP_0001945","EFO_0004992","MONDO_0004979","HP_0100607","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever and has 3 investigational indications."}
{"id":"CHEMBL279898","canonicalSmiles":"CCCn1c(=O)[nH]c(=O)c2[nH]cnc21","inchiKey":"SIQPXVQCUCHWDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENPROFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D 4028","D-4028","Enprofylline"],"crossReferences":{"PubChem":["104171214","11111643","144203783","50104067","855784","90341781"],"Wikipedia":["Enprofylline"],"drugbank":["DB00824"],"chEBI":["126237"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29392","canonicalSmiles":"NCCCCCCCCN","inchiKey":"PWGJDPKCLMLPJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMINOOCTANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diaminooctane"],"crossReferences":{"drugbank":["DB04333"],"chEBI":["73112"]},"childChemblIds":["CHEMBL3216710"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301141","canonicalSmiles":"O=c1cc(O)c2ccccc2o1","inchiKey":"VXIXUWQIVKSKSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-HYDROXYCOUMARINS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxycoumarin"],"crossReferences":{"PubChem":["76718"],"Wikipedia":["4-Hydroxycoumarins"],"drugbank":["DB03410"],"chEBI":["40070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL312862","canonicalSmiles":"CN[C@H]1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(OC)c(=O)cc21","inchiKey":"NNJPGOLRFBJNIW-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECOLCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-12669","Colchamine","Deacetyl-n-methylcolchicine","Demecolcine","NSC-3096","Substance f"],"crossReferences":{"PubChem":["144205849","164339377","56320682","56320683"],"Wikipedia":["Demecolcine"],"drugbank":["DB13318"],"chEBI":["4393"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3186993","canonicalSmiles":"Cl.Cl.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ANOMHKZSQFYSBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYZINE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL896","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atarax","Hydroxyzine","Hydroxyzine hydrochloride","Orgatrax","Ucerax","Vistaril"],"synonyms":["Hydroxizine chloride","Hydroxyzine dihydrochloride","Hydroxyzine hydrochloride"],"crossReferences":{"DailyMed":["hydroxyzine%20hydrochloride"],"PubChem":["26752325"],"chEBI":["5819"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL3219616","canonicalSmiles":"CC[C@@]1(c2cccc(NS(C)(=O)=O)c2)[C@H]2CN(CC3(O)Cc4ccccc4C3)C[C@H]21","inchiKey":"ZBVPUFSKFGYNLC-FIDNPTQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-866087","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-866,087","Cp-866,087","Cp-866087"],"crossReferences":{"drugbank":["DB12196"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","MONDO_0007079","EFO_0001073"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301611","canonicalSmiles":"Nc1ccncc1N.O=P(O)(O)O","inchiKey":"KAICRBBQCRKMPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIFAMPRIDINE PHOSPHATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL354077","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firdapse"],"synonyms":["3,4-DAPP","Amifampridine phosphate","DAPP","Zenas"],"crossReferences":{"DailyMed":["amifampridine%20phosphate"]},"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000053918","ENSG00000168263","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000177301","ENSG00000168418","ENSG00000135519","ENSG00000089558","ENSG00000158445","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000184611","ENSG00000171385"],"count":40},"linkedDiseases":{"rows":["EFO_0008525","Orphanet_130","EFO_0009851","EFO_0004991"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for myasthenia gravis and has 4 investigational indications."}
{"id":"CHEMBL347862","canonicalSmiles":"NOCC(=O)O","inchiKey":"NQRKYASMKDDGHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOXYMETHOXYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminooxy-Acetic Acid","Carboxymethoxylamine"],"crossReferences":{"PubChem":["90340597","11110738"],"Wikipedia":["Aminooxyacetic_acid"],"drugbank":["DB02079"]},"childChemblIds":["CHEMBL1255757","CHEMBL1492415"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544921","drugType":"Enzyme","blackBoxWarning":false,"name":"CERLIPONASE ALFA","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brineura"],"synonyms":["BMN 190","BMN-190","Cerliponase alfa","Immature tripeptidyl-peptidase i"],"crossReferences":{"DailyMed":["cerliponase%20alfa"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL3544969","drugType":"Small molecule","blackBoxWarning":false,"name":"HM-71224","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hm-71224"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545046","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2849466","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2849466"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["HP_0004326"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545172","drugType":"Small molecule","blackBoxWarning":false,"name":"CNV2197944","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNV2197944","Cnv-2197944","Cnv2197944"],"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","MONDO_0041052"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545206","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK1482160","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK1482160","Gsk-1482160","Gsk1482160"],"linkedTargets":{"rows":["ENSG00000089041"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545241","canonicalSmiles":"Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1","inchiKey":"DCRWIATZWHLIPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AC-430","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC430","Ac-430"],"crossReferences":{"drugbank":["DB12535"]},"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3586573","canonicalSmiles":"CCN1C(=O)CNc2ncc(-c3ccc(-c4nc[nH]n4)nc3C)nc21","inchiKey":"GMYLVKUGJMYTFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3586573","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12740"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL366312","canonicalSmiles":"OCCNc1ncnc2[nH]c(-c3ccccc3)c(-c3ccccc3)c12","inchiKey":"MPJYGQHMIFDQIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL366312","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707212","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"GTFUITFQDGVJSK-XGXHKTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTONORONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gestonorone"],"crossReferences":{"drugbank":["DB13230"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707301","canonicalSmiles":"COc1ccc(C2(c3ccc(OC)cc3)NC(=O)N(CCN3CCCCC3)C2=O)cc1","inchiKey":"HVYGXNYMNHSBGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDANPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gabil","Idanpramine"],"crossReferences":{"drugbank":["DB13276"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707310","canonicalSmiles":"Cc1cc(C2=NO[C@@](c3cc(Cl)c(Cl)c(Cl)c3)(C(F)(F)F)C2)sc1C(=O)NCC(=O)NCC(F)(F)F","inchiKey":"HDKWFBCPLKNOCK-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOTILANER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Credelio","Lotilaner","Lotilaner (ema epar: veterinary)"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707325","drugType":"Antibody","blackBoxWarning":false,"name":"LENZILUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KB-003","KB003","Lenzilumab"],"linkedTargets":{"rows":["ENSG00000164400"],"count":1},"linkedDiseases":{"rows":["EFO_0003106","EFO_0000685","EFO_1001779","MONDO_0100096","EFO_0000096","MONDO_0004979"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3833314","canonicalSmiles":"Cl[Al](Cl)Cl.O.O.O.O.O.O","inchiKey":"JGDITNMASUZKPW-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833401","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anhydrol fte","Driclor","Gppe a-pers","Odaban"],"synonyms":["Aluminium chloride","Aluminum chloride"],"crossReferences":{"DrugCentral":["4436"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for acne."}
{"id":"CHEMBL388751","canonicalSmiles":"OCC(O)COc1ccc(Cl)cc1","inchiKey":"MXOAEAUPQDYUQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL388751","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207103"],"drugbank":["DB00856"],"chEBI":["3642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415247","canonicalSmiles":"CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1","inchiKey":"ZLVXBBHTMQJRSX-VMGNSXQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JDTIC","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jdtic","Rti-jdtic"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4208229","canonicalSmiles":"O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1","inchiKey":"VOVZXURTCKPRDQ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASCIMINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABL-001","ABL001","ABL001-NX","Abl-001","Asciminib","NVP-ABL001"],"crossReferences":{"drugbank":["DB12597"]},"childChemblIds":["CHEMBL4297220"],"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","MONDO_0003060","EFO_0000339","EFO_0000220"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL420937","canonicalSmiles":"C[C@@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"GSDSWSVVBLHKDQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROFLOXACINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111577","11112864"],"drugbank":["DB03034"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297240","drugType":"Gene","blackBoxWarning":false,"name":"ONASEMNOGENE ABEPARVOVEC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AVXS-101","Onasemnogene abeparvovec","Zolgensma"],"linkedTargets":{"rows":["ENSG00000172062","ENSG00000205571"],"count":2},"linkedDiseases":{"rows":["EFO_0008525","Orphanet_139525","Orphanet_1145","Orphanet_83419","Orphanet_404521","Orphanet_139547","Orphanet_139518","Orphanet_98920","Orphanet_83418","Orphanet_83330","Orphanet_139552"],"count":11},"description":"Gene drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4297505","canonicalSmiles":"CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CO","inchiKey":"KJKKMMMRWISKRF-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENERIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-334441","ACT334441","Act-334441","Cenerimod"],"crossReferences":{"drugbank":["DB12705"]},"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0002690","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297608","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O","inchiKey":"FZEXGDDBXLBRTD-AYIMTCTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELDECALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ed-71","Eldecalcitol"],"crossReferences":{"drugbank":["DB05295"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0003882"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297690","drugType":"Protein","blackBoxWarning":false,"name":"NOGAPENDEKIN ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALT-803","Alt-803","IL-15N72D","N-803","Nogapendekin alfa"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL4297883","drugType":"Antibody","blackBoxWarning":false,"name":"IVUXOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-ox40 antibody pf-04518600","Ivuxolimab","PF-04518600","PF-8600","PF04518600","Pf-04518600","Pf04518600"],"linkedTargets":{"rows":["ENSG00000186827"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000349","EFO_0000196","EFO_0000222","MONDO_0018906","EFO_0000305","EFO_0000311"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297919","drugType":"Unknown","blackBoxWarning":false,"name":"PAROXETINE HYDROCHLORIDE HEMIHYDRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL29060A","Brl29060a","Paroxetine hydrochloride","Paroxetine hydrochloride hemihydrate","Paroxetine hydrochloride hydrate"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_1001917"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297938","drugType":"Antibody","blackBoxWarning":false,"name":"LIFASTUZUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNIB-0600A","DNIB0600A","Dnib0600a","Lifastuzumab vedotin","NAPI3B","RG-7599"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000157765","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["MONDO_0008170","EFO_0003060"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298027","drugType":"Unknown","blackBoxWarning":false,"name":"PRX-321","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Il4(38-37)-pe38kdel","MDNA55","Mdna55","NBI-3001","PRX-321","PRX321","Prx-321"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298029","drugType":"Unknown","blackBoxWarning":false,"name":"MEDI-0639","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-0639","MEDI0639","Medi 0639","Medi-0639","Medi0639"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298187","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"FERRIC DERISOMALTOSE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diafertm","Monofartm","Monoferric","Monoferrictm","Monoferrotm","Monofertm","Monovertm"],"synonyms":["Ferric derisomaltose","NS32"],"crossReferences":{"DailyMed":["ferric%20derisomaltose"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for anemia and iron deficiency anemia and has 1 investigational indication."}
{"id":"CHEMBL4298200","drugType":"Cell","blackBoxWarning":false,"name":"LIFILEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Autologous tumor infiltrating lymphocytes","LN-144","LN-145","Lifileucel","Ln-145"],"description":"Cell drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL430341","canonicalSmiles":"C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O)C3","inchiKey":"GIPHUOWOTCAJSR-NCGAPWICSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"REBAUDIOSIDE A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-960A","FEMA NO. 4601","Glycoside x","INS NO.960A","INS-960A","Reb-a 97","Rebaudiana a","Rebaudioside a","Rebiana","Sooolite!-pure","Stevioside a3","Sweetener 4g-s","Truvia"],"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL450940","canonicalSmiles":"C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12","inchiKey":"MQIMZDXIAHJKQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRINABEREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ERB-041","PF-00913086","Prinaberel"],"crossReferences":{"drugbank":["DB06832"]},"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0001065","HP_0001657","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL454","canonicalSmiles":"C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O","inchiKey":"UZVHFVZFNXBMQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTALBITAL","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sandoptal"],"synonyms":["Alisobumal","Allylbarbituric acid","Butalbital","Butalbital ciii","Itobarbital","Tetrallobarbital"],"crossReferences":{"DailyMed":["butalbital"],"Wikipedia":["Butalbital"],"drugbank":["DB00241"],"chEBI":["102524"]},"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for migraine disorder."}
{"id":"CHEMBL455461","canonicalSmiles":"CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(CNCc4cnn[nH]4)cc3)c(F)c2)C(=O)O1","inchiKey":"BTTNOGHPGJANSW-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADEZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RX-013","RX-01_667","RX-103","RX-1741","RX-O1_667","Radezolid"],"crossReferences":{"Wikipedia":["Radezolid"],"drugbank":["DB12339"]},"childChemblIds":["CHEMBL2105651"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594252","canonicalSmiles":"O=[Al]O[Al]=O","inchiKey":"TWNQGVIAIRXVLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINIUM OXIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alum ox","Brasivol 1","Brasivol 2","Brasivol 3"],"synonyms":["Alumina","Aluminium lake","Aluminium oxide","Aluminum lake","Aluminum oxide","Aluminum oxide, activated","Aluminum oxide, anhydrous"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for acne."}
{"id":"CHEMBL4594264","drugType":"Small molecule","blackBoxWarning":false,"name":"AIR POLYMER-TYPE A","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exem foam kit"],"synonyms":["Air polymer-type a","Exem foam"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019."}
{"id":"CHEMBL4594305","canonicalSmiles":"CC(=O)N1CCC2(CC1)c1cc(C#C[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)ccc1-c1ccc(C#C[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)cc12","inchiKey":"SFHMWDMKUYVSQJ-VECBPBMLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIBOFIMLOC","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EB-8018","EB8018","Sibofimloc","VRT-1353385"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594474","drugType":"Unknown","blackBoxWarning":false,"name":"FN-1501","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FN-1501","Fn-1501"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594490","drugType":"Unknown","blackBoxWarning":false,"name":"RECAP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ilofotase alfa","Recap"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594616","drugType":"Unknown","blackBoxWarning":false,"name":"BISMUTH TRIBROMOPHENATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bismuth tribromophenate","Dressing,xeroform","Sigmaform","Xeroform"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL463588","canonicalSmiles":"CC(C)(CCl)C(=O)Nc1ccc(C(F)(F)F)cc1","inchiKey":"QCQZFHOGRCQNIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL463588","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817013"],"drugbank":["DB07805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650337","canonicalSmiles":"CNC[C@@H]1OCCc2ccsc21","inchiKey":"ABDDQTDRAHXHOC-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULOTARONT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SEP-363856","SEP-856","Sep-363856","Ulotaront"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650436","drugType":"Unknown","blackBoxWarning":false,"name":"AGN-211745","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN 211745","AGN-211745","AGN-745","Agn 211745","Agn-211745","SIRNA-027"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL467399","canonicalSmiles":"COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C","inchiKey":"QULDDKSCVCJTPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIIB021","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB 021","BIIB-021","Biib021","CNF2024","Cnf-2024","Cnf2024"],"crossReferences":{"PubChem":["124954167"],"drugbank":["DB12359"],"chEBI":["90687"]},"childChemblIds":["CHEMBL3526911","CHEMBL557165"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","Orphanet_44890","MONDO_0007254","EFO_0000574"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL477486","canonicalSmiles":"Nc1nc2c(ncn2[C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"HAAZLUGHYHWQIW-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYGUANOSINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["deoxyguanosine triphosphate"],"crossReferences":{"Wikipedia":["Deoxyguanosine_triphosphate"],"drugbank":["DB02181"],"chEBI":["16497"]},"childChemblIds":["CHEMBL2368456"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479579","canonicalSmiles":"CC(C)C[C@H](NP(=O)(O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O","inchiKey":"ZPHBZEQOLSRPAK-XLCYBJAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHORAMIDON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphoramidon","Phosphramidon","Phosporamidon"],"crossReferences":{"Wikipedia":["Phosphoramidon"],"drugbank":["DB02557"],"chEBI":["45353"]},"childChemblIds":["CHEMBL2028192"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL499458","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"OGWKCGZFUXNPDA-CFWMRBGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL499458","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["164339426"],"drugbank":["DB00541"]},"childChemblIds":["CHEMBL385978"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501351","canonicalSmiles":"C=C1CCC2CC1C2(C)C","inchiKey":"WTARULDDTDQWMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA-PINENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-Pinene"],"crossReferences":{"PubChem":["144207227"],"Wikipedia":["Beta-Pinene"],"drugbank":["DB15574"],"chEBI":["50025"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL512283","canonicalSmiles":"C[C@](O)(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"SSFVOEAXHZGTRJ-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL512283","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07419"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL529437","canonicalSmiles":"COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C.Cl","inchiKey":"PIQVDUKEQYOJNR-VZXSFKIWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"COCAINE HYDROCHLORIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL370805","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Goprelto","Numbrino"],"synonyms":["Cocaine hcl","Cocaine hydrochloride","Cocaine hydrochloride cii","Cocaine muriate","Cocainum muriaticum","MCV 4526","NIH 8211","NSC-25263","RX-0041-002"],"crossReferences":{"DailyMed":["cocaine%20hydrochloride"],"PubChem":["144206436"],"chEBI":["613010"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0002610"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL535","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c1C","inchiKey":"WINHZLLDWRZWRT-ATVHPVEESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUNITINIB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"crossReferences":{"DailyMed":["sunitinib%20malate"],"PubChem":["124893176","26758053","50100120"],"Wikipedia":["Sunitinib"],"drugbank":["DB01268"],"chEBI":["38940"]},"childChemblIds":["CHEMBL3109278","CHEMBL3542310","CHEMBL1567"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721","ENSG00000182578","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000403","EFO_0000637","EFO_0000558","EFO_0000756","EFO_0000681","EFO_0000228","EFO_1000984","EFO_0000632","EFO_1001951","EFO_0000588","MONDO_0003268","MONDO_0008903","EFO_0000182","EFO_0000501","EFO_0008528","EFO_1000251","EFO_0000641","MONDO_0015277","EFO_0000514","EFO_0007243","EFO_1000045","EFO_0002618","EFO_0000220","MONDO_0008170","EFO_0000349","EFO_1001968","MONDO_0004986","MONDO_0008315","EFO_0005221","EFO_0007143","EFO_0000294","MONDO_0002691","EFO_1000576","Orphanet_398934","MONDO_0044787","EFO_0001378","EFO_1000796","MONDO_0021640","EFO_0002938","MONDO_0004192","EFO_1001901","EFO_0007416","EFO_1001465","MONDO_0007254","EFO_0004252","MONDO_0002087","EFO_0000350","MONDO_0020654","MONDO_0001187","Orphanet_892","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0006352","EFO_1001974","EFO_0000673","EFO_0000196","EFO_0002499","EFO_0000239","EFO_1000042","EFO_0002617","HP_0001541","EFO_0000616","EFO_0003897","EFO_1000616","EFO_0007331","Orphanet_44890","EFO_0000403","MONDO_0007576","EFO_0000313","EFO_0000222","EFO_0004243","EFO_0003060","MONDO_0003865","EFO_0000311","EFO_0000640","EFO_0003863","EFO_0003865","EFO_1000581","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0004142","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000519","EFO_0003833","EFO_0000181","MONDO_0044926"],"count":93},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 7 approved and 91 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL569","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1","inchiKey":"MFDFERRIHVXMIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCAINE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-169497","Novocain","Procaine"],"crossReferences":{"PubChem":["11111696","11111697","90341175"],"Wikipedia":["Procaine"],"drugbank":["DB00721"],"chEBI":["8430"]},"childChemblIds":["CHEMBL1200841"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000764","EFO_0009552","EFO_0003102"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for hemorrhoid and has 2 investigational indications."}
{"id":"CHEMBL575218","canonicalSmiles":"COc1cc(-c2ccc(C)cc2)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"QVXYJVHNRPNRJL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL575218","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07141"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL591118","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2","inchiKey":"GUYMHFIHHOEFOA-ZCPGHIKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMEGLIPTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carmegliptin","R-1579","R1579","RO-4876904","RO4876904"],"crossReferences":{"drugbank":["DB12268"]},"childChemblIds":["CHEMBL2105633"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL592878","canonicalSmiles":"CC(=O)N[C@]1(C(N)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"BUPVODXECQDZQR-YCOWOFQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL592878","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL593791","canonicalSmiles":"CN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O","inchiKey":"RIUIMUSXAGXXON-FMTWGGRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593791","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03479"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL700","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1","inchiKey":"GECHUMIMRBOMGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPYRIDINE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coccoclase","Concord 693","Dagenan","Eubasin","Piridazol","Sulfanilamidopyridine","Sulfapyridine"],"synonyms":["NSC-41791","NSC-4753","Sulfapyridine","Sulphapyridine"],"crossReferences":{"PubChem":["11112302","144203977","170464707","26746948","855656"],"Wikipedia":["Sulfapyridine"],"drugbank":["DB00891"],"chEBI":["132842"]},"childChemblIds":["CHEMBL2105500"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939 and is indicated for bacterial disease."}
{"id":"CHEMBL89363","canonicalSmiles":"Cc1c[nH]c(/C=C2\\C(=O)Nc3ccccc32)c1CCC(=O)O","inchiKey":"JNDVEAXZWJIOKB-JYRVWZFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-5402","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-5402"],"crossReferences":{"drugbank":["DB08577"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94394","canonicalSmiles":"CCCCOc1ccc(CC(=O)NO)cc1","inchiKey":"MXJWRABVEGLYDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFEXAMAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anderm","Duradermal","Paraderm","Parfenac"],"synonyms":["Bufexamac","Butoxyphenylacethydroxamic acid","CP 1044 J3","CP-1044-J3","NSC-758153"],"crossReferences":{"PubChem":["11112517","124882428","124882430","144204073","170465813","26746938","56422414","855633"],"drugbank":["DB13346"],"chEBI":["31317"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
